Skip to content

Epimed 107-1614Recalls & reported problems

Epimed International, Inc · RX-2™ Coudé® Epidural Needle 14g TW x 6.0" · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818788020376), received between Oct 15, 2025 and Oct 15, 2025 — classified as 1 injury.

1 other recall cover devices cleared under the same FDA submission (K053318); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Cerebrospinal Fluid Leakage1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 15, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    DURING A TRIAL IMPLANT PROCEDURE FOR THE EVOKE SPINAL CORD STIMULATION (SCS) SYSTEM, THE PATIENT EXPERIENCED A CEREBROSPINAL FLUID (CSF) LEAK AND THE PHYSICIAN ELECTED TO ABORT THE PROCEDURE. FOLLOWING DAY, THE PATIENT WAS EVALUATED AT THE EMERGENCY DEPARTMENT AND A BLOOD PATCH PROCEDURE WAS COMPLETED. THE PATIENT WAS DISCHARGED THREE (3) DAYS LATER WITH ALL SYMPTOMS RESOLVED.

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 23277405 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K053318. One submission often covers many models, so check the product and lot details in each record.

  • Z-0087-2018 · Jul 24, 2017 · Terminated
    RX-2 COUDE Epidural Needle, 16g x 3.5in (8.9cm)TW, 10 units, Calibrated, Plastic Hub, Detachable Wing, Blunt Stylet, Sterile, Rx only, For Use with 19g or Smaller Catheter

Other NEEDLE, CONDUCTION, ANESTHETIC (W/WO INTRODUCER) devices

All NEEDLE, CONDUCTION, ANESTHETIC (W/WO INTRODUCER) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page